Perm Medical Journal
ISSN 0136-1449 (Print)
ISSN 2687-1408 (Online)
Menu
Archives
Home
About the Journal
Editorial Team
Editorial Policies
Author Guidelines
About the Journal
Issues
Search
Current
Articles in press
Retracted articles
Archives
Contact
Subscriptions
All Journals
User
Username
Password
Remember me
Forgot password?
Register
Notifications
View
Subscribe
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
By Sections
Other Journals
Categories
BMJ Open News
The Lancet News
[19.10.2025] [Comment] Perioperative camrelizumab plus rivoceranib versus surgery in...
[19.10.2025] [Comment] The arrival of antibody drug conjugates in nasopharyngeal cancer
[20.10.2025] [Articles] Zanzalintinib plus atezolizumab versus regorafenib in refractory...
[19.10.2025] [Articles] Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug...
[19.10.2025] [Articles] Ivonescimab plus chemotherapy versus tislelizumab plus...
PubMed News Global
[20.10.2025] Reconsidering rebound malaria: Zanzibari voices on acquired immunity, risk,...
[20.10.2025] Behavioural and cognitive changes in young adults towards food and nutrition...
[20.10.2025] Dimethyl fumarate reprograms cervical cancer cells to enhance antitumor...
[20.10.2025] Impact of mouse tracheal basal cell expansion medium on formation and...
[20.10.2025] DCFFNet: A New Dual-channel Cross-Feature Fusion Net for Evaluating the...
Current Issue
×
User
Username
Password
Remember me
Forgot password?
Register
Notifications
View
Subscribe
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
By Sections
Other Journals
Categories
BMJ Open News
The Lancet News
[19.10.2025] [Comment] Perioperative camrelizumab plus rivoceranib versus surgery in...
[19.10.2025] [Comment] The arrival of antibody drug conjugates in nasopharyngeal cancer
[20.10.2025] [Articles] Zanzalintinib plus atezolizumab versus regorafenib in refractory...
[19.10.2025] [Articles] Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug...
[19.10.2025] [Articles] Ivonescimab plus chemotherapy versus tislelizumab plus...
PubMed News Global
[20.10.2025] Reconsidering rebound malaria: Zanzibari voices on acquired immunity, risk,...
[20.10.2025] Behavioural and cognitive changes in young adults towards food and nutrition...
[20.10.2025] Dimethyl fumarate reprograms cervical cancer cells to enhance antitumor...
[20.10.2025] Impact of mouse tracheal basal cell expansion medium on formation and...
[20.10.2025] DCFFNet: A New Dual-channel Cross-Feature Fusion Net for Evaluating the...
Current Issue
Home
>
Archives
>
Vol 38, No 3 (2021)
>
PDF
Vol 38, No 3 (2021) - PDF (Russian)
Download this PDF file
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ:
серия
ЭЛ № ФС 77 - 75489
от 05.04.2019 г
.
TOP